Headlines
-
$1.7m for peer support
Wednesday | Feb 8 2023THE Federal Government has invested $1.7m to extend The Essential Network (TEN) project until 30 Jun 2024.
-
Pfizer takes a pulse check on beliefs
Wednesday | Feb 8 2023A RECENT survey of 1,075 Australians aged 18 years and older, released by Pfizer yesterday, provides a snapshot of common attitudes and behaviours of Australian adults around health and wellbeing, with 83% looking to improve their understanding of health and wellbeing matters.
-
Patients ‘bullied’ on brand substitution
Tuesday | Feb 7 2023THE Australian Thyroid Foundation (ATF) has slammed pharmacists as it continues to receive complaints from patients being given a different brand of medication than what they usually take and have been prescribed.
-
Nominations are open for PATY 2023
Tuesday | Feb 7 2023NOMINATIONS for the prestigious Pharmacy Guild of Australia/Maxigesic Pharmacy Assistant of the Year Award (PATY) 2023 are now open.
-
Single dose for Gardasil
Tuesday | Feb 7 2023AUSTRALIA has moved from two doses to a single dose of the Gardasil 9 human papillomavirus (HPV) vaccine for routine immunisation of young people under the National Immunisation Program, the Health Minister Mark Butler has announced.
-
Pathway to major Medicare reforms
Monday | Feb 6 2023THE Pharmacy Guild has welcomed the agreement among federal, state and territory leaders to make health reform a priority over the next 12 months.
-
John Skerritt to retire
Monday | Feb 6 2023THE public face of the Therapeutic Goods Administration (TGA), Prof John Skerritt (pictured), has decided to retire (PD breaking news Fri) from his position of Deputy Secretary Health Products Regulation Group, effective from 18 Apr.
-
Paracetamol pack sizes to change
Monday | Feb 6 2023THE TGA has published an interim decision to reduce the maximum pack sizes for various paracetamol products.
-
NZ fluoxetine shortages
Monday | Feb 6 2023PHARMACISTS in New Zealand are struggling with a short supply of fluoxetine hydrochloride, with the country's national medicines procurement agency Pharmac confirming there are issues around a change in brands from Fluox to Arrow-Fluoxetine.
-
Call for an MBS fee for immunisers: PSA
Friday | Feb 3 2023THE Pharmaceutical Society of Australia (PSA) has used its pre-Budget submission to urge the Federal Government to introduce a Medicare Benefits Schedule (MBS) payment for pharmacist immunisations modelled on the Level B payment available to GPs.
